Voltar
Carta Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

2020; European Respiratory Society; Volume: 56; Issue: 1 Linguagem: Inglês

10.1183/13993003.01398-2020

ISSN

1399-3003

Autores

Marina Tadolini, Luigi Ruffo Codecasa, José-María García-García, F.–X. Blanc, Borisov Se, Jan‐Willem C. Alffenaar, Claire Andréjak, Pierre Bachez, Pierre-Alexandre Bart, Evgeny Belilovski, José Landivar, Rosella Centis, Lia D’Ambrosio, María Luiza de Souza-Galvão, Ángel Domínguez-Castellano, Samir Dourmane, M. Jachym, Antoine Froissart, Vania Giacomet, Delia Goletti, S. Grard, Gina Gualano, A. Izadifar, Damien Le Dû, Margarita Marín Royo, Jesica Mazza‐Stalder, Ilaria Motta, Ong C, Fabrizio Palmieri, F. Rivière, Teresa Rodrigo, Denise Rossato Silva, Adrián Sánchez‐Montalvá, Matteo Saporiti, Paolo Scarpellini, F. Schlemmer, Antonio Spanevello, Elena Sumarokova, Eva Tabernero, Paul Anantharajah Tambyah, Simon Tiberi, Alessandro Torre, Dina Visca, Miguel Zabaleta Murguiondo, Giovanni Sotgiu, Giovanni Battista Migliori,

Tópico(s)

SARS-CoV-2 and COVID-19 Research

Resumo

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5]. Diagnostic, treatment and outcome details of 49 COVID-19 patients with concurrent or previous tuberculosis from 8 countries show varied clinical profiles The article is part of the scientific activities of the Global Tuberculosis Network (GTN); GREPI (Groupe de Recherche et d'Enseignement en Pneumo-Infectiologie), a working group from SPLF (Société de Pneumologie de Langue Française); SEPAR (Sociedad Española de Neumología and Cirugía Torácica); Moscow Society of Phtisiology and of the WHO Collaborating Centre for Tuberculosis and Lung Diseases, Tradate, ITA-80, 2017-2020- GBM/RC/LDA). Delia Goletti is a professor of Pathology at Unicamillus University in Rome, Italy. The authors wish to thank Enrico Girardi (National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Rome, Italy) for the useful comments on the manuscript.

Referência(s)